Tagged as: sovaldi
Will Federal Regulators Take Action Against Pharmaceutical Price-Gouging?
Pharmaceutical companies have been notoriously price-gouging. The recent scandal centered around the ridiculously inflated cost of Daraprim showed how carelessly pricing is regulated.Many have been left wondering if federal lawmakers will take action a...
Obama’s New Budget Aims to Make Biotech Treatments More Affordable
The Obama administration recently revealed its new $3.99 trillion budget for 2016. It announced its plans to negotiate prices for costly drugs and biotechnology treatments under the Medicare Part D program, which offers private coverage for senior citizens...